|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Lupus
|
NIAMS
|
5R03AR052041-03
|
|
The role of estrogen receptors in B cell autoreactivity
|
GRIMALDI, CHRISTINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$78,505
|
|
Lupus
|
NIAID
|
4R37AI045196-11
|
|
Genetic Pathways Contributing to SLE Pathogenesis
|
WAKELAND, EDWARD
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$446,593
|
|
Lupus
|
NCCAM
|
1R01AT004259-01
|
|
Therapeutic Value of Fish Oil Rx on SLE and Bone Loss in Mice
|
FERNANDES, GABRIEL
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$325,600
|
|
Lupus
|
NIAID
|
5R01AI032137-17
|
|
A Transgenic Model for B Cell Tolerance and Autoimmunity
|
ERIKSON, JAN
|
WISTAR INSTITUTE
|
PA
|
$496,668
|
|
Lupus
|
NIAID
|
5R01AI059305-04
|
|
Molecular regulation of immune complex disease
|
KOEHL, JOERG
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$346,486
|
|
Lupus
|
NIAID
|
5R01AI063288-04
|
|
Mechanism of protection of DAF and CD59 in SLE
|
SONG, WENCHAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$368,577
|
|
Lupus
|
NIAID
|
5R01AI068820-02
|
|
Mechanisms of Immunosuppressive Actions of Glucocorticoids
|
ROGATSKY, INEZ
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$386,085
|
|
Lupus
|
NIAID
|
5R01AI063274-05
|
|
Comprehensive Candidate Pathway Analysis in SLE
|
GAFFNEY, PATRICK
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$711,323
|
|
Lupus
|
NIAID
|
5R01AI038965-11
|
|
Negative Selective of Autoreactive Antibodies
|
MANSER, TIMOTHY
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$380,138
|
|
Lupus
|
NIAID
|
5R01AI063496-03
|
|
Immune Regulation by Gadd45b and Gadd45g
|
LU, BINFENG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$301,640
|
|
Lupus
|
NIAID
|
5R01AI059893-03
|
|
Interferon in Systemic Lupus Erythematosus
|
CROW, MARY
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$404,835
|
|
Lupus
|
NIAID
|
5R01AI072627-02
|
|
Fas in host defense and autoimmune diseases
|
CHERVONSKY, ALEXANDER
|
UNIVERSITY OF CHICAGO
|
IL
|
$376,459
|
|
Lupus
|
NIAID
|
5R01AI037562-12
|
|
IMMUNOLOGIC MECHANISMS THAT PREVENT AUTOIMMUNITY
|
CANTOR, HARVEY
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$407,216
|
|
Lupus
|
NIAID
|
5R01AI059718-04
|
|
IPC Developmental Pathways and Regulation
|
LIU, YONG-JUN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$351,137
|
|
Lupus
|
NIAID
|
5R01AI047859-08
|
|
Antigens of the RNA-induced silencing complex in autoimmunity
|
CHAN, EDWARD
|
UNIVERSITY OF FLORIDA
|
FL
|
$323,362
|
|
Lupus
|
NIAID
|
5R01AI054912-02
|
|
Immune Tolerance Mediated by Negative Costimulatory Molecules
|
DONG, CHEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$377,685
|
|
Lupus
|
NIGMS
|
5F31GM076982-03
|
|
Role of Hyperresponsive Myeloid Cells in Murine Lupus
|
GUTIERREZ, MARIA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$29,325
|
|
Lupus
|
NIEHS
|
5F30ES014519-03
|
|
Complement deficiency and environment in autoimmunity
|
NICHOLAS, MATILDA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$28,048
|
|
Lupus
|
NIAID
|
5R37AI046776-09
|
|
MECHANISMS OF IMMUNE TOLERANCE INDUCED IN MURINE LUPUS
|
HAHN, BEVRA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$444,228
|
|
Lupus
|
NIAID
|
5R01AI069253-03
|
|
The role of activated NK cells in a mouse model of lupus erythematosus
|
YUAN, DOROTHY
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$373,877
|
|
Lupus
|
NIAID
|
5R01AI063626-25
|
|
Mechanisms of autoreactivity in SLE
|
EISENBERG, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$310,828
|
|
Lupus
|
NIAID
|
5R01AI065483-04
|
|
Mechanisms of TLR 9 Activation
|
GOLENBOCK, DOUGLAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$340,091
|
|
Lupus
|
NIAID
|
5R01AI068965-03
|
|
Genetic dissection of Sle2 contribution to SLE pathogenesis
|
MOREL, LAURENCE
|
UNIVERSITY OF FLORIDA
|
FL
|
$342,998
|
|
Lupus
|
NINDS
|
5R01NS049111-03
|
|
Neurological Indices of CNS Involvement in "Non-CNS" SLE
|
SHUCARD, JANET
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$297,297
|
|
Lupus
|
NIAMS
|
5R01AR042242-12
|
|
Pathogenesis of Murine Systemic Lupus Erythematosus
|
KONO, DWIGHT
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$387,391
|
|
Lupus
|
NIAID
|
5R01AI057471-06
|
|
Molecular mechanisms of autoreactive B cell activation
|
DAL PORTO, JOSEPH
|
ROCHE PALO ALTO, LLC
|
CA
|
$232,541
|
|
Lupus
|
NIAID
|
5R01AI059777-04
|
|
Cell Cycle Inhibition in Systemic Autoimmunity
|
KONO, DWIGHT
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$440,665
|
|
Lupus
|
NIAID
|
5R01AI061167-04
|
|
Receptor Editing in Autoimmune and Normal Mice
|
FEENEY, ANN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$389,066
|
|
Lupus
|
NIAID
|
5R01AI063622-04
|
|
Identifying the novel SLE susceptibility gene on 5p15.3
|
NATH, SWAPAN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$287,421
|
|
Lupus
|
NIAID
|
1R01AI077058-01
|
|
TAM Receptor Regulation of Innate Immunity
|
LEMKE, GREG
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
CA
|
$478,750
|
|
Lupus
|
NIAID
|
5R01AI059636-03
|
|
Interferon Regulation in Systemic Lupus
|
IVASHKIV, LIONEL
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$399,343
|
|
Lupus
|
NIEHS
|
1R01ES016302-01
|
|
Oxidative Stress and Autoimmunity
|
KHAN, M. FIROZE
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$320,875
|
|
Lupus
|
NIAID
|
5R37AI024717-20
|
|
Genetic Linkage in Lupus
|
HARLEY, JOHN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$359,276
|
|
Lupus
|
NIAID
|
1R03AI076729-01
|
|
IL-21 polymorphisms in systemic lupus erythematosus
|
SAWALHA, AMR
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$63,000
|
|
Lupus
|
NCI
|
5R01CA078846-10
|
|
Subpopulations of Human Dendritic Cells
|
BANCHEREAU, JACQUES
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$292,811
|
|
Lupus
|
NIAID
|
5R21AI070306-02
|
|
Sex Chromosome Effects in Lupus
|
VOSKUHL, RHONDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$189,456
|
|
Lupus
|
NIAID
|
5R01AI049344-07
|
|
Complement regulatory proteins and autoimmune disease
|
SONG, WENCHAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$386,269
|
|
Lupus
|
NIAID
|
5R01AI046712-09
|
|
Steroid Therapy and Cytokines in Rheumatic Diseases
|
IVASHKIV, LIONEL
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$355,790
|
|
Lupus
|
NIAID
|
5R01AI067497-03
|
|
Regulation of Type I Interferon Gene Expression in the Innate Immune Response
|
FITZGERALD, KATHERINE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$386,974
|
|
Lupus
|
NIDDK
|
1R01DK074661-01A2
|
|
Modeling SLE Nephritis Through Urine MCP-1
|
ROVIN, BRAD
|
OHIO STATE UNIVERSITY
|
OH
|
$202,500
|
|
Lupus
|
NIDDK
|
5R01DK071057-03
|
|
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
|
BRAUN, MICHAEL
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$289,685
|
|
Lupus
|
NIAID
|
5R01AI041985-28
|
|
GENETIC, VIRAL & IMMUNOLOGIC STUDIES IN NEW ZEALAND MICE
|
DATTA, SYAMAL
|
NORTHWESTERN UNIVERSITY
|
IL
|
$328,181
|
|
Lupus
|
NHLBI
|
1R01HL088364-01A1
|
|
Accelerated Atherosclerosis and system lupus erythematosus
|
MAJOR, AMY
|
VANDERBILT UNIVERSITY
|
TN
|
$374,655
|
|
Lupus
|
NIAID
|
5R21AI069458-02
|
|
Molecular identification of a sialyl 9-O-acetyl transferase
|
PILLAI, SHIV
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$214,594
|
|
Lupus
|
NIEHS
|
1R01ES014847-01A2
|
|
Role of Daf in Systemic Autoimmunity
|
POLLARD, KENNETH
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$383,738
|
|
Lupus
|
NIAID
|
5R01AI068842-03
|
|
Altered CD8+ T cell Compartment in SLE Patients
|
BANCHEREAU, JACQUES
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$363,160
|
|
Lupus
|
NIAID
|
5R37AI026296-18
|
|
Cognate Activation of B-Lymphocytes
|
NOELLE, RANDOLPH
|
DARTMOUTH COLLEGE
|
NH
|
$330,675
|
|
Lupus
|
NHLBI
|
5R01HL065082-07
|
|
Vascular Damage in SLE
|
STEIN, CHARLES
|
VANDERBILT UNIVERSITY
|
TN
|
$335,359
|
|
Lupus
|
NIAID
|
1R01AI073722-01A1
|
|
Activation and regulation of autoreactive B cells in health and disease
|
SHLOMCHIK, MARK
|
YALE UNIVERSITY
|
CT
|
$463,299
|
|
Lupus
|
NIDDK
|
5R01DK073960-03
|
|
Towards Molecular Diagnostics of Glomerular Disease
|
BOTTINGER, ERWIN
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$303,535
|
|
Lupus
|
NIAID
|
2R01AI047466-07A2
|
|
Immunopathogenesis of Lupus
|
VIA, CHARLES
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$384,750
|
|
Lupus
|
NIAID
|
5U01AI067146-04
|
|
HLA Region Genetics and SLE in U.S. Black Women
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$339,507
|
|
Lupus
|
NIAID
|
5R01AI033613-15
|
|
Immune Recognition and Tolerance of Antibody Diversity
|
WYSOCKI, LAWRENCE
|
NATIONAL JEWISH HEALTH
|
CO
|
$317,281
|
|
Lupus
|
NIAMS
|
5R01AR042460-14
|
|
Genetic Association in American Blacks with Lupus
|
HARLEY, JOHN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$497,210
|
|
Lupus
|
NIAMS
|
5R01AR051203-04
|
|
End Organ Failure Controlled by IL-2 and Fas
|
JU, SHYR-TE
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$311,753
|
|
Lupus
|
NIAID
|
5R01AI069371-03
|
|
Defining genetic pathways to severe systemic autoimmunity
|
WAKELAND, EDWARD
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$578,419
|
|
Lupus
|
NIAMS
|
2K24AR002207-06A2
|
|
Patient-oriented research in skin autoimmune disease
|
WERTH, VICTORIA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$145,042
|
|
Lupus
|
NIAMS
|
1K23AR052736-01A2
|
|
Cohort Study of Pediatric SLE
|
SULE, SANGEETA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$135,540
|
|
Lupus
|
NIAMS
|
5R03AR052470-03
|
|
B cell antigen presentation in models of B cell a*
|
SHIMODA, MICHIKO
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$69,941
|
|
Lupus
|
NIAMS
|
2R37AR042455-16
|
|
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus
|
BUYON, JILL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$372,350
|
|
Lupus
|
NINDS
|
5R01NS050627-03
|
|
Cognitive Function in SLE (COGNITION)
|
BREY, ROBIN
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$856,727
|
|
Lupus
|
NIAID
|
5R01AI068787-02
|
|
Phosphatases in Human Lupus
|
TSOKOS, GEORGE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$409,824
|
|
Lupus
|
NIAID
|
2R01AI049954-07A1
|
|
Gene Transcription In SLE
|
TSOKOS, GEORGE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$425,000
|
|
Lupus
|
NIAID
|
5R01AI047450-07
|
|
Mechanistic Studies of Pro-Apoptotic Benzodiazepines
|
GLICK, GARY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$325,772
|
|
Lupus
|
NHLBI
|
5R01HL085907-02
|
|
Blood Pressure, Renal Hemodynamics, and Inflammation
|
RYAN, MICHAEL
|
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
|
MS
|
$293,237
|
|
Lupus
|
NIAMS
|
5R01AR053734-03
|
|
The X Chromosome in Systemic Lupus Erythematosus
|
SCOFIELD, R
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$267,041
|
|
Lupus
|
NIAMS
|
5R01AR052300-04
|
|
Novel strategies for defining the role of HLA in SLE
|
CRISWELL, LINDSEY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$551,022
|
|
Lupus
|
NIAMS
|
5R21AR054980-02
|
|
Nucleoprotein Immune Complexes and Interferon in Diffuse Neuropsychiatric SLE
|
ELKON, KEITH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$164,346
|
|
Lupus
|
NIGMS
|
5R01GM044809-19
|
|
B lymphocyte Tolerance in Health and Autoimmunity
|
NEMAZEE, DAVID
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$382,730
|
|
Lupus
|
NIAMS
|
5R03AR053376-02
|
|
The role of Fli1 in the pathogenesis of lupus
|
NOWLING, TAMARA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$71,540
|
|
Lupus
|
NIAMS
|
5K01AR051391-05
|
|
Genetics of Autontibody Diversification
|
DESHMUKH, UMESH
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$104,548
|
|
Lupus
|
NIAMS
|
5K23AR051044-05
|
|
Investigation and Validation of Novel Biomarkers for SLE
|
KAO, AMY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$123,202
|
|
Lupus
|
NIAID
|
5R01AI041090-12
|
|
Interaction of Clq on Phagocytic Cells
|
TENNER, ANDREA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$326,844
|
|
Lupus
|
NIDDK
|
5R01DK055357-08
|
|
Pathogenic role of the complement system in murine lupus
|
QUIGG, RICHARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$333,010
|
|
Lupus
|
NIAMS
|
5R01AR050193-03
|
|
The vital role of BAFF in the development of SLE
|
STOHL, WILLIAM
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$341,237
|
|
Lupus
|
NIDDK
|
5R01DK069769-03
|
|
Autoimmunity and Pathogenesis of Glomerulonephritis
|
BAGAVANT, HARINI
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$295,537
|
|
Lupus
|
NIAMS
|
5K08AR054317-02
|
|
Characterization of a new mouse model of autoimmune cardiac valve disease
|
BINSTADT, BRYCE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$128,844
|
|
Lupus
|
NIAID
|
1F31AI075609-01A1
|
|
Role of the MHC Class II tranactivator gene in lupus and rheumatoid arthritis
|
BRONSON, PAOLA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$30,803
|
|
Lupus
|
NIAID
|
5R01AI031105-15
|
|
Mouse Membrane RCA Proteins in the Immune Response
|
HOLERS, V
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$333,030
|
|
Lupus
|
NIAID
|
5R01AI051436-06
|
|
Complement Convertase: Assembly, Function and Regulation
|
HOURCADE, DENNIS
|
WASHINGTON UNIVERSITY
|
MO
|
$260,946
|
|
Lupus
|
NIAMS
|
5K24AR002138-09
|
|
Patient Oriented Research: Systemic Lupus Erythematosus
|
RAMSEY-GOLDMAN, ROSALIND
|
NORTHWESTERN UNIVERSITY
|
IL
|
$91,938
|
|
Lupus
|
NIAMS
|
5R01AR050267-04
|
|
Admixture Mapping Development and Testing in AA SLE
|
SELDIN, MICHAEL
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$488,121
|
|
Lupus
|
NIAID
|
5R01AI070860-02
|
|
TFE3 and TFEB in CD40L Dependent Murine Autoimmunity and Human Lupus
|
ROMAN, CHRISTOPHER
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$344,331
|
|
Lupus
|
NIAMS
|
5K01AR051367-04
|
|
Lupus Serum Signaling Through Toll-Like Receptor 9
|
MEANS, TERRY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$128,520
|
|
Lupus
|
NIDDK
|
5R01DK036149-21
|
|
Cell Mediated Renal Injury In Lupus
|
KELLEY, VICKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$327,085
|
|
Lupus
|
NIAID
|
5K08AI071072-02
|
|
Modified autoantigens engage the innate immune response in systemic autoimmunity
|
GRADER-BECK, THOMAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$129,007
|
|
Lupus
|
NCI
|
5R03CA128052-02
|
|
Lymphoma in Autoimmune Disease: Consequence of Immune Suppression or Stimulation?
|
BERNATSKY, SASHA
|
MCGILL UNIVERSITY HEALTH CTR RES INST
|
CANADA
|
$54,000
|
|
Lupus
|
NIAID
|
5R01AI059829-05
|
|
Immunogenetic Studies of Autoimmune Disease
|
BARCELLOS, LISA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$352,570
|
|
Lupus
|
NIAMS
|
5K01AR053573-02
|
|
Sphingosine 1-Phosphate Signaling in Autoimmune Regulation
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$129,464
|
|
Lupus
|
NHLBI
|
5R01HL088648-02
|
|
Prothrombin Gene Variation and the Risk of SLE and CHD
|
KAMBOH, M
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$474,249
|
|
Lupus
|
NIGMS
|
5R01GM073863-04
|
|
RNA quality control and environmental stress
|
WOLIN, SANDRA
|
YALE UNIVERSITY
|
CT
|
$399,154
|
|
Lupus
|
NIAID
|
5R13AI065123-04
|
|
FASEB Summer Conference on 'Autoimmunity'
|
VON HERRATH, MATTIAS
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$1
|
|
Lupus
|
NINDS
|
5R13AI065123-04
|
|
FASEB Summer Conference on 'Autoimmunity'
|
VON HERRATH, MATTIAS
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$5,000
|
|
Lupus
|
NIAID
|
5R01AI057473-05
|
|
Cytokine mechanisms in systemic lupus erythematosus
|
JACOB, CHAIM
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$379,042
|
|
Lupus
|
NIAID
|
5R01AI044970-09
|
|
Biology of decay accelerating factor
|
SONG, WENCHAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$331,721
|
|
Lupus
|
NIAMS
|
5R03AR054546-02
|
|
Mechanisms of autoreative B cell development in a lupus animal model
|
ZHANG, XIAN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$71,540
|
|
Lupus
|
NIAID
|
1R01AI077591-01
|
|
Lymphocyte-Bound Complement Activation Products: Clues to SLE Pathogenesis
|
LIU, CHAU-CHING
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$189,375
|
|
Lupus
|
NHLBI
|
5R01HL062215-06
|
|
Signaling Cascades in Humoral Immunity and Autoimmunity
|
PERNIS, ALESSANDRA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$362,250
|
|
Lupus
|
NIAID
|
1K02AI077708-01
|
|
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect
|
FRIEDMAN, JENNIFER
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$104,490
|
|
Lupus
|
NIAID
|
5R01AI068063-03
|
|
Cell Death and Antibody-Mediated Protection from Autoimmunity
|
SILVERMAN, GREGG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$350,207
|
|
Lupus
|
NIDDK
|
5K01DK068292-06
|
|
Role of Lyn in Systemic lupus erythematosus-like autoimmune disease in mice
|
GUPTA, NEETU
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$117,911
|
|
Lupus
|
NIAMS
|
5R37AR040072-19
|
|
IMMUNE RESPONSES IN LUPUS
|
CRAFT, JOSEPH
|
YALE UNIVERSITY
|
CT
|
$303,853
|
|
Lupus
|
NHLBI
|
1K02HL092284-01
|
|
Blood Pressure, Renal Hemodynamics, and Inflammation
|
RYAN, MICHAEL
|
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
|
MS
|
$77,870
|
|
Lupus
|
NIAID
|
5R01AI068759-02
|
|
Mapping Autoimmune Phenotypes in Multiplex Families
|
GREGERSEN, PETER
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$783,262
|
|
Lupus
|
NIDDK
|
5R21DK074805-02
|
|
Role of defective clearance of apoptotic beta-cell in pathogenesis of T1D
|
MA, ZHONGMIN
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$207,638
|
|
Lupus
|
NIAMS
|
5K08AR050937-04
|
|
The Role of Epstein Barr Virus in Systemic Lupus Erythematosus
|
QUAN, TIMOTHY
|
YALE UNIVERSITY
|
CT
|
$125,954
|
|
Lupus
|
NIAMS
|
5R01AR038889-16
|
|
Mechanisms of aPL antibody-induced pregnancy loss
|
SALMON, JANE
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$366,359
|
|
Lupus
|
NIAMS
|
5R03AR054070-03
|
|
ROLE OF IRF5 IN SLE PATHOGENESIS
|
BARNES, BETSY
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$73,985
|
|
Lupus
|
NIAMS
|
5K24AR002213-07
|
|
Vascular Disease in Systemic Lupus Erythematosus
|
MANZI, SUSAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$148,824
|
|
Lupus
|
NIAMS
|
5R01AR053239-03
|
|
Role of Leptin in Systemic Lupus Erythematosus
|
LA CAVA, ANTONIO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$323,441
|
|
Lupus
|
NIAMS
|
5R01AR053228-03
|
|
TYPE I INTERFERONS IN LUPUS
|
THEOFILOPOULOS, ARGYRIOS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$389,177
|
|
Lupus
|
NIEHS
|
5R01ES015214-03
|
|
Environmental effects on lupus T cell DNA methylation and gene expression
|
RICHARDSON, BRUCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$356,718
|
|
Lupus
|
NIAID
|
1R15AI072756-01A2
|
|
The anti-inflammatory effects of CeO2 nanoparticles in SLE
|
REILLY, CHRISTOPHER
|
VIRGINIA COLLEGE OF OSTEOPATHIC MEDICINE
|
VA
|
$253,917
|
|
Lupus
|
NIAID
|
1R21AI078459-01
|
|
Cellular Origins of HIV Broadly Neutralizing Antibodies
|
SANZ, IGNACIO
|
UNIVERSITY OF ROCHESTER
|
NY
|
$229,650
|
|
Lupus
|
NIAID
|
1R01AI072429-01A2
|
|
The cell biology of Toll-like receptor 9: a mechanism to prevent autoimmunity
|
BARTON, GREGORY
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$334,097
|
|
Lupus
|
NIAID
|
1R01AI075157-01A1
|
|
Dissecting the role for IL-15 in CD8+ T cell homeostasis in human lupus
|
CRAFT, JOSEPH
|
YALE UNIVERSITY
|
CT
|
$413,230
|
|
Lupus
|
NIAID
|
1R01AI070984-01A2
|
|
The Role of Dendritic Cells and Macrophages in Systemic Lupus Erythematosus
|
VILEN, BARBARA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$179,195
|
|
Lupus
|
NIAMS
|
2R01AR049772-06
|
|
Predictors of Pregnancy Outcome In SLE and APS
|
SALMON, JANE
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$904,726
|
|
Lupus
|
OD
|
2R01AR049772-06
|
|
Predictors of Pregnancy Outcome In SLE and APS
|
SALMON, JANE
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$500,000
|
|
Lupus
|
NIAID
|
2R01AI048120-06A1
|
|
Post Translational Modifications in Tolerance and Autoimmunity
|
MAMULA, MARK
|
YALE UNIVERSITY
|
CT
|
$413,438
|
|
Lupus
|
NIDDK
|
1R01DK077857-01A1
|
|
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
|
LOU, YAHUAN
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$224,063
|
|
Lupus
|
NIAID
|
1R01AI074948-01A1
|
|
Molecular Regulation of VH Gene Replacement in Human Immature B Cells
|
ZHANG, ZHIXIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$290,000
|
|
Lupus
|
NIAID
|
1R01AI071110-01A2
|
|
Suppression of pathogenic autoantibodies in lupus by inhibition of AID
|
MOUNTZ, JOHN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$362,500
|
|
Lupus
|
NIAMS
|
2R01AR043727-10A1
|
|
Hopkins Lupus Cohort
|
PETRI, MICHELLE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$662,654
|
|
Lupus
|
NIAMS
|
2R01AR034156-22A1
|
|
Experimental Induction of SLE by Altered Ia
|
EISENBERG, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$346,500
|
|
Lupus
|
NIAMS
|
2R01AR031203-25
|
|
T Cell Homeostasis in Systemic Autoimmunity
|
THEOFILOPOULOS, ARGYRIOS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$416,900
|
|
Lupus
|
NIAMS
|
1R01AR054459-01A2
|
|
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
|
YU, CHACK
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$191,800
|
|
Lupus
|
OD
|
1R01AR054459-01A2
|
|
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
|
YU, CHACK
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$125,000
|
|
Lupus
|
NIAMS
|
1R21AR056626-01A2
|
|
Drug Compound Screening for Dermatomyositis and Systemic Lupus Erythematosus
|
GREENBERG, STEVEN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$192,500
|
|
Lupus
|
NIDDK
|
1R21DK077279-01A2
|
|
Accurate profiles of IgA1 O-glycan heterogeneity in IgA nephropathy
|
RENFROW, MATTHEW
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$206,250
|
|
Lupus
|
NIAID
|
5R01AI058150-05
|
|
B Cell Developmental Defect in Murine Lupus
|
MOREL, LAURENCE
|
UNIVERSITY OF FLORIDA
|
FL
|
$312,401
|
|
Lupus
|
NIAID
|
2R01AI045050-09
|
|
Characterization of SLE-Susceptability Loci on Mouse Chromosome 1
|
MOREL, LAURENCE
|
UNIVERSITY OF FLORIDA
|
FL
|
$410,878
|
|
Lupus
|
NIAID
|
5R01AI048115-08
|
|
The role of Immunoglobulin CDRH3 in Autoimmune Disease
|
SCHROEDER, HARRY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$311,841
|
|
Lupus
|
NIDDK
|
1R21DK077331-01A2
|
|
Protein Phenotyping of SLE Nephritis Flare Cycle
|
ROVIN, BRAD
|
OHIO STATE UNIVERSITY
|
OH
|
$225,000
|
|
Lupus
|
NIAMS
|
5R01AR041032-13
|
|
Molecular Mechanisms of Lymphocyte Interactions in Autoimmunity
|
MAMULA, MARK
|
YALE UNIVERSITY
|
CT
|
$313,838
|
|
Lupus
|
NIAMS
|
5R01AR048796-08
|
|
Apoptotic Cells as Immunogens in SLE
|
ELKON, KEITH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$293,924
|
|
Lupus
|
NIAMS
|
5R01AR049449-04
|
|
HLA-D Region in Systemic Lupus Erythematosus Pathogenesis
|
FU, SHU MAN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$327,458
|
|
Lupus
|
NIAMS
|
5K08AR049444-05
|
|
Pathogen-specific T cell responses in patients with SLE
|
KANG, INSOO
|
YALE UNIVERSITY
|
CT
|
$126,090
|
|
Lupus
|
NIAMS
|
5R01AR044077-12
|
|
Role of B cells and DCs in Lupus pathogenesis
|
SHLOMCHIK, MARK
|
YALE UNIVERSITY
|
CT
|
$444,760
|
|
Lupus
|
NIAID
|
1R01AI072648-01A2
|
|
Metabolic control of systemic autoimmunity
|
PERL, ANDRAS
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$274,750
|
|
Lupus
|
NIAMS
|
5K23AR051314-05
|
|
Psychosocial Influences on Systemic Lupus
|
GRECO, CAROL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$106,000
|
|
Lupus
|
NIAMS
|
5R01AR047988-08
|
|
Cellular and Genetic Basis of Systemic Lupus
|
FU, SHU MAN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$309,708
|
|
Lupus
|
NIAMS
|
5R37AR039157-20
|
|
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
|
DATTA, SYAMAL
|
NORTHWESTERN UNIVERSITY
|
IL
|
$275,977
|
|
Lupus
|
NIAID
|
1R01AI076475-01A1
|
|
Excessive Receptor Editing and Generation of Autoreactive Antibodies in SLE
|
ZHANG, ZHIXIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$290,000
|
|
Lupus
|
NIAMS
|
2P60AR047784-06A2
|
0005
|
Improved Diagnostics & Advanced Magnetic Resonance Imaging for Pediatric NPSLE
|
BRUNNER, HERMINE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$265,498
|
|
Lupus
|
NIAMS
|
5R01AR035230-21
|
|
B Cell Hyperactivity in Autoimmunity
|
MARSHAK-ROTHSTEIN, ANN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$306,171
|
|
Lupus
|
NIAID
|
5R01AI061487-06
|
|
Role of natural autoantibodies in autoimmune disease
|
CHEN, QING
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$310,793
|
|
Lupus
|
NIAMS
|
2P01AR049084-06
|
0001
|
Copy Number Variation in Chromosome 1 Candidates
|
KIMBERLY, ROBERT
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$244,972
|
|
Lupus
|
NIAMS
|
2P01AR049084-06
|
0002
|
Genomics of Lupus Associations in the Hispanic 12q24 Linkage
|
HARLEY, JOHN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$268,141
|
|
Lupus
|
NIAMS
|
2P01AR049084-06
|
0003
|
Mapping of Systemic Lupus Erythematosus (SLE) Susceptibility in African Americans
|
NATH, SWAPAN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$268,141
|
|
Lupus
|
NIAMS
|
2P01AR049084-06
|
0004
|
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts
|
ALARCON, GRACIELA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$418,267
|
|
Lupus
|
NIAMS
|
2P01AR049084-06
|
9001
|
Genetic Epidemiology and Biostatistics Core
|
ALLISON, DAVID
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$208,524
|
|
Lupus
|
NIAMS
|
5R01AR049938-04
|
|
Novel Costimulatory Antagonists for SLE
|
DAVIDSON, ANNE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$400,952
|
|
Lupus
|
NIAID
|
5R01AI070983-03
|
|
Functional Analysis of Complement Receptor 2 as a Lupus Susceptibility Gene
|
BOACKLE, SUSAN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$527,187
|
|
Lupus
|
NIAID
|
5F31AI071694-03
|
|
B Cell Memory Development During Systemic Autoimmunity
|
SWEET, REBECCA
|
YALE UNIVERSITY
|
CT
|
$39,848
|
|
Lupus
|
NIAMS
|
5K23AR052364-02
|
|
The Role of Vitamin D in Systemic Lupus Erythematosus
|
KAMEN, DIANE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$29,465
|
|
Lupus
|
OD
|
5K23AR052364-02
|
|
The Role of Vitamin D in Systemic Lupus Erythematosus
|
KAMEN, DIANE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$100,000
|
|
Lupus
|
NIAMS
|
5K23AR051522-05
|
|
Impact of Medications on Outcomes in Lupus
|
FESSLER, BARRI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$121,978
|
|
Lupus
|
NIAAA
|
5R01AA016399-03
|
|
Complement and ethanol-induced liver injury.
|
NAGY, LAURA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$337,544
|
|
Lupus
|
NIGMS
|
1F32GM084567-01
|
|
Regulation of Phosphoinositide 4-Phosphate Signaling at the Plasma Membrane
|
BAIRD, DANIEL
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$49,646
|
|
Lupus
|
NIAMS
|
5R01AR044076-13
|
|
Genetic Analysis of T Cells in Lupus
|
CRAFT, JOSEPH
|
YALE UNIVERSITY
|
CT
|
$346,471
|
|
Lupus
|
NIAMS
|
5R01AR046588-07
|
|
Progression of Cardiovascular Disease in Lupus.
|
MANZI, SUSAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$606,105
|
|
Lupus
|
NIAID
|
5R01AR055088-03
|
|
Endothelial reactivity and nitric oxide synthetase activity in the ALMS (Aspreva
|
CLANCY, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$169,453
|
|
Lupus
|
NIAMS
|
5R01AR055088-03
|
|
Endothelial reactivity and nitric oxide synthetase activity in the ALMS (Aspreva
|
CLANCY, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$180,824
|
|
Lupus
|
NIAMS
|
5R03AR054067-04
|
|
Tailored Messaging for Couple Chronic Illness Management
|
LEWIS, MEGAN
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$81,117
|
|
Lupus
|
NIAMS
|
5R01AR043274-13
|
|
Gene Mapping in Women with Systemic Lupus Erythematosus
|
MOSER, KATHY
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$556,671
|
|
Lupus
|
NIAID
|
5R01AI066261-04
|
|
Gender-Specific Role of p202 in Lupus Susceptibility
|
CHOUBEY, DIVAKER
|
UNIVERSITY OF CINCINNATI
|
OH
|
$290,211
|
|
Lupus
|
NIAMS
|
5R01AR044731-12
|
|
Pathogenesis on Autoantibodies in Pristane-Induced Lupus
|
REEVES, WESTLEY
|
UNIVERSITY OF FLORIDA
|
FL
|
$306,693
|
|
Lupus
|
NIAMS
|
5R01AR053731-02
|
|
Defining the effector gene repertoire in systemic autoimmunity by ENU mutagenesis
|
KONO, DWIGHT
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$490,964
|
|
Lupus
|
NIAMS
|
5R03AR054530-02
|
|
Tissue-Specific Expression and Regulation of the Inhibitory lgG Fc Receptor
|
SU, KAIHONG
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$69,634
|
|
Lupus
|
NIAMS
|
5U01AR055054-02
|
|
Efficacy Measures for Pediatric Lupus Studies
|
BRUNNER, HERMINE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$193,224
|
|
Lupus
|
NHLBI
|
5R01HL077422-03
|
|
Libman-Sacks Endocarditis and NPSLE
|
ROLDAN, CARLOS
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$518,903
|
|
Lupus
|
NIAMS
|
5R03AR053704-02
|
|
Role of TRAIL in Lupus Nephritis
|
RUS, VIOLETA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$73,500
|
|
Lupus
|
NIAMS
|
5R03AR054034-02
|
|
Delineating the Role of Selected Genes in Lupus Induced by CD8+Ti and CD4+CD25 T
|
SINGH, RAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$75,460
|
|
Lupus
|
NIAID
|
5F31AI071292-03
|
|
Minority Predoctoral Fellowship Program
|
GILBERT, MILEKA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$28,641
|
|
Lupus
|
NIAMS
|
5R01AR052125-04
|
|
Genetic and functional studies of the CD40 P227A polymorphism
|
GAFFNEY, PATRICK
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$285,177
|
|
Lupus
|
NIAMS
|
5R03AR054909-02
|
|
Dissecting the protective and pathogenic functions of TNF alpha in SLE
|
RAMANUJAM, MEERA
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$81,176
|
|
Lupus
|
NIAID
|
5R01AI068819-02
|
|
Thymocyte tuning after selection: mechanisms to avoid autoreactivity
|
LAUFER, TERRI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$386,269
|
|
Lupus
|
RMAP
|
5R01GM081798-02
|
|
Structural Biology of G Protein-Coupled Receptors
|
NAVARRO, JAVIER
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$186,669
|
|
Lupus
|
NIAMS
|
5R01AR049126-08
|
|
Antibodies to NR2 in SLe
|
DIAMOND, BETTY
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$356,262
|
|
Lupus
|
NIGMS
|
5R01GM020964-34
|
|
Genetics and Regulation of Autoantibodies
|
WEIGERT, MARTIN
|
UNIVERSITY OF CHICAGO
|
IL
|
$565,315
|
|
Lupus
|
NCCAM
|
5R21AT004349-02
|
|
Mechanism of Modulation of Interleukin-12 Production by Triptolide
|
MA, XIAOJING
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$192,629
|
|
Lupus
|
NIAMS
|
5K23AR053202-02
|
|
Neurocognitive Function in Childhood-Onset SLE (cSLE)
|
LEVY, DEBORAH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$129,708
|
|
Lupus
|
NIAID
|
1R21AI076176-01A2
|
|
Origin of Antibodies with Long CDR-H3 Loops in HIV Infection & Autoimmune Disease
|
SCOTT, JAMIE
|
SIMON FRASER UNIVERSITY
|
CANADA
|
$136,895
|
|
Lupus
|
NIAMS
|
5R01AR051545-02
|
|
Mechanisms of Tolerance to Renal Maternal Microchimerism
|
STEVENS, ANNE
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$392,314
|
|
Lupus
|
NIAMS
|
5R01AR043308-13
|
|
Immune Response to Small Nuclear Ribonucleoprotein Autoantigens
|
HOFFMAN, ROBERT
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$322,371
|
|
Lupus
|
RMAP
|
5RL1GM084437-02
|
|
Driving Medical Projects (4 of 4)
|
SCOLNICK, EDWARD
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$1,176,777
|
|
Lupus
|
NIAID
|
5R21AI065645-02
|
|
Molecular Basis of Suppression of SLE by CD8+ Ti Cells
|
SINGH, RAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$113,306
|
|
Lupus
|
NIDDK
|
5F32DK078416-02
|
|
The role of CSF-1 in the pathogenesis of lupus nephritis
|
LUCAS, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$51,278
|
|
Lupus
|
NIAID
|
1R01AI079056-01
|
|
The roles of Sirt1, a deacetylase, in immune tolerance and autoimmunity
|
FANG, DEYU
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$356,425
|
|
Lupus
|
NIAMS
|
1R21AR056370-01
|
|
OGT Overexpression in Women with Lupus
|
RICHARDSON, BRUCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$1
|
|
Lupus
|
OD
|
1R21AR056370-01
|
|
OGT Overexpression in Women with Lupus
|
RICHARDSON, BRUCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$196,965
|
|
Lupus
|
OD
|
1R21AI079616-01
|
|
Do estrogen receptors in B cells and DC mediate sex bias in murine lupus?
|
KOVATS, SUSAN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$198,750
|
|
Lupus
|
NIAMS
|
1R03AR055701-01A1
|
|
Impact of lupus susceptibility loci on peripheral tolerance and onset of disease
|
RAHMAN, ZIAUR
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$77,250
|
|
Lupus
|
NIAMS
|
1R01AR056465-01
|
|
Gender Bias in Lupus: Contribution of Sex Chromosomes
|
SINGH, RAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$213,800
|
|
Lupus
|
OD
|
1R01AR056465-01
|
|
Gender Bias in Lupus: Contribution of Sex Chromosomes
|
SINGH, RAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$125,000
|
|
Lupus
|
NIAID
|
1P01AI073693-01A1
|
0001
|
Mechanisms of neurotoxicity of lupus anti-NMDAR antibodies: Electrophysiology to
|
HUERTA, PATRICIO
|
BURKE REHABILITATION CENTER
|
NY
|
$868,289
|
|
Lupus
|
NIAID
|
1P01AI073693-01A1
|
0002
|
Developmental neurotoxicity: Maternal anti-NMDAR antibodies and fetal development
|
VOLPE, BRUCE
|
BURKE REHABILITATION CENTER
|
NY
|
$237,103
|
|
Lupus
|
NIAID
|
1P01AI073693-01A1
|
0003
|
Imaging neurotoxicity: The effect of anti-NMDAR Ab on hippocampus and amygdala in
|
HIRSCH, JOY
|
COLUMBIA UNIVERSITY
|
NY
|
$245,496
|
|
Lupus
|
NIAID
|
1P01AI073693-01A1
|
0004
|
Preventing anti-NMDAR Ab neurotoxicity: Rational therapies for NPSLE
|
DIAMOND, BETTY
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$182,377
|
|
Lupus
|
NIAID
|
1P01AI073693-01A1
|
9003
|
Histology Core
|
DEGIORGIO, LORRAINE
|
BURKE REHABILITATION CENTER
|
NY
|
$101,473
|
|
Lupus
|
NIAMS
|
1R01AR056478-01A1
|
|
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
|
WARD, ELIZABETH
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$345,400
|
|
Lupus
|
NCI
|
1P01CA128913-01A1
|
0001
|
Molecular Mechanisms of pDC Interactions
|
LIU, YONG-JUN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$207,621
|
|
Lupus
|
NIDDK
|
1R01DK079989-01A1
|
|
Immune and genetic determinants of murine glomerulonephritis
|
PAUL, ELAHNA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$363,812
|
|
Lupus
|
NIAMS
|
9R01AR056962-11A1
|
|
Anti-Sm B Cell Regulation
|
CLARKE, STEPHEN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$416,755
|
|
Lupus
|
NIDDK
|
1R01DK063005-01A1
|
|
Genetic control of renal disease in lupus-prone mice
|
MCDUFFIE, MARCIA
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$102,250
|
|
Lupus
|
OD
|
1R01DK063005-01A1
|
|
Genetic control of renal disease in lupus-prone mice
|
MCDUFFIE, MARCIA
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$125,000
|
|
Lupus
|
NIAMS
|
2R01AR056476-06
|
|
Health Systems, Quality of Care, and Outcomes in SLE
|
YELIN, EDWARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$398,313
|
|
Lupus
|
NIAID
|
2R01AI034662-22A1
|
|
Study of FcR Genes: Macrophages and Lymphocytes
|
RAVETCH, JEFFREY
|
ROCKEFELLER UNIVERSITY
|
NY
|
$457,914
|
|
Lupus
|
NIAID
|
1R01AI076562-01A1
|
|
The Role of CD5 in B-Cell Development and Autoimmunity
|
RAMAN, CHANDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$362,500
|
|
Lupus
|
NIAID
|
1R01AI071078-01A2
|
|
Modulating Immunity through Dendritic Cell Phagocytic Receptors
|
BHARDWAJ, NINA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,541
|
|
Lupus
|
NIAMS
|
2R01AR043814-10A2
|
|
Association of Positional Candidate Gene Variants with SLE
|
TSAO, BETTY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$527,663
|
|
Lupus
|
NIAID
|
2R01AI042269-12A1
|
|
Lymphocyte Signaling Defects in Patients with Lupus
|
TSOKOS, GEORGE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$425,000
|
|
Lupus
|
NIAMS
|
2R01AR045476-09A1
|
|
Role of reactive intermediates in lupus nephritis
|
GILKESON, GARY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$302,164
|
|
Lupus
|
NIAID
|
1R01AI070544-01A2
|
|
PTPN22 and Autoimmunity
|
BOTTINI, NUNZIO
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$351,000
|
|
Lupus
|
NCCAM
|
1R01AT004332-01A1
|
|
Treatment of SLE with N-acetylcysteine
|
PERL, ANDRAS
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$392,500
|
|
Lupus
|
NIAMS
|
1K23AR055672-01A1
|
|
NFAT/AP-1 cooperation in SLE T cells
|
KYTTARIS, VASILEIOS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$95,580
|
|
Lupus
|
NIAMS
|
1K23AR055671-01A1
|
|
Advanced glycation end products in SLE: Lupus factor for Cardiovascular Disease?
|
MAKSIMOWICZ-MCKINNON, KATHLEEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$124,929
|
|
Lupus
|
NIAID
|
1K08AI073739-01A2
|
|
Progesterone and Estrogen Differentially Regulate DC Functions in Lupus Autoimmun
|
HUGHES, GRANT
|
UNIVERSITY OF WASHINGTON
|
WA
|
$122,040
|
|
Lupus
|
NIAMS
|
2R01AR050812-05A1
|
|
IMMUNOGENETICS OF ANTIBODY INDUCED NEPHRITIS
|
MOHAN, CHANDRA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$345,400
|
|
Lupus
|
NIAMS
|
1R01AR055646-01A1
|
|
Tertiary lymphoid neogenesis in human lupus nephritis
|
CLARK, MARCUS
|
UNIVERSITY OF CHICAGO
|
IL
|
$338,800
|
|
Lupus
|
NIAID
|
2R01AI042265-10A2
|
|
CD19 Tyrosine-mediated Signal Transduction in vivo
|
JUSTEMENT, LOUIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$362,500
|
|
Lupus
|
NIDDK
|
1R01DK080799-01A1
|
|
Molecular pathogenesis of anti-glomerular basement membrane nephritis
|
BORZA, DORIN-BOGDAN
|
VANDERBILT UNIVERSITY
|
TN
|
$326,188
|
|
Lupus
|
NIAID
|
2R44AI066483-02
|
|
Development of an inhibitory oligonucleotide for the treatment of lupus
|
COFFMAN, ROBERT
|
DYNAVAX TECHNOLOGIES CORPORATION
|
CA
|
$878,519
|
|
Lupus
|
NIAID
|
1F32AI080104-01
|
|
Examining a role for G alpha q in preventing autoimmune disease
|
MISRA, RAVI
|
UNIVERSITY OF ROCHESTER
|
NY
|
$49,646
|
|
Lupus
|
NIAID
|
1F31AI080184-01
|
|
The role of E2-2 in the development and function of plasmacytoid dendritic cells
|
CISSE, BABACAR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$45,972
|
|
Lupus
|
NIAMS
|
1F31AR056957-01
|
|
Role of the mTOR Pathway in T cell Dysfunction in SLE
|
FERNANDEZ, DAVID
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$36,252
|
|
Lupus
|
NIAID
|
1P01AI078869-01
|
0003
|
The contribution of innate immune cells to autoimmunity
|
LOWELL, CLIFFORD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$198,801
|
|
Lupus
|
NIAID
|
3R01AI059893-03S1
|
|
Interferon in Systemic Lupus Erythematosus
|
CROW, MARY
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$36,859
|
|
Lupus
|
NCI
|
5S06GM008168-28
|
0063
|
Role of EBNA-1 in Eliciting Anti-dsDNA Antibodies
|
SPATZ, LINDA
|
CITY COLLEGE OF NEW YORK
|
NY
|
$46,016
|
|
Lupus
|
NIAID
|
5S06GM008168-28
|
0063
|
Role of EBNA-1 in Eliciting Anti-dsDNA Antibodies
|
SPATZ, LINDA
|
CITY COLLEGE OF NEW YORK
|
NY
|
$55,851
|
|
Lupus
|
NIGMS
|
5S06GM008168-28
|
0063
|
Role of EBNA-1 in Eliciting Anti-dsDNA Antibodies
|
SPATZ, LINDA
|
CITY COLLEGE OF NEW YORK
|
NY
|
$99,629
|
|
Lupus
|
NIDDK
|
3R01DK036149-20S1
|
|
Cell Mediated Renal Injury In Lupus
|
KELLEY, VICKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$57,000
|
|
Lupus
|
NIAID
|
5U19AI067152-04
|
0006
|
Systemic Lupus Erythematosus and Ulcerative Colitis Study
|
RIOUX, JOHN
|
MONTREAL HEART INSTITUTE
|
CANADA
|
$225,885
|
|
Lupus
|
NINDS
|
5U19AI067152-04
|
0006
|
Systemic Lupus Erythematosus and Ulcerative Colitis Study
|
RIOUX, JOHN
|
MONTREAL HEART INSTITUTE
|
CANADA
|
$16,787
|
|
Lupus
|
NIAID
|
5U19AI067152-04
|
0007
|
Systemic Lupus Erythematosus and Ulcerative Colitis Study
|
VYSE, TIMOTHY
|
IMPERIAL COLLEGE OF SCIENCE-TECHNOLOGY
|
UK
|
$120,114
|
|
Lupus
|
NINDS
|
5U19AI067152-04
|
0007
|
Systemic Lupus Erythematosus and Ulcerative Colitis Study
|
VYSE, TIMOTHY
|
IMPERIAL COLLEGE OF SCIENCE-TECHNOLOGY
|
UK
|
$8,926
|
|
Lupus
|
NIAMS
|
5P60AR053308-03
|
0001
|
The Interplay of Sociodemographic and Genetic Factors in SLE Health Disparities
|
CRISWELL, LINDSEY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$141,360
|
|
Lupus
|
NIAMS
|
5P60AR053308-03
|
0002
|
SLE and Employment: The Impact of Individual and Contextual Factors
|
YELIN, EDWARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$78,907
|
|
Lupus
|
NIAMS
|
5P60AR053308-03
|
0004
|
Body Composition and Disability in RA and SLE
|
KATZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$64,472
|
|
Lupus
|
NHLBI
|
5P50HL081011-03
|
0006
|
ROLE OF MICROPARTICLES IN THE ANTI-PHOSPHOLIPID SYNDROME
|
MCCRAE, KEITH
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$328,774
|
|
Lupus
|
NIAMS
|
2R01AR033625-25
|
|
Purification of Epidermolysis Bullosa Antigen
|
WOODLEY, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$245,000
|
|
Lupus
|
OD
|
2R56DK047424-14A1
|
|
Proximal Determinants of Nephritogenic Autoimmunity
|
FOSTER, MARY
|
DUKE UNIVERSITY
|
NC
|
$237,900
|
|
Lupus
|
NIAID
|
5P01AI039824-12
|
0007
|
Genetic Mechanisms to Suppress Autoimmunity
|
WAKELAND, EDWARD
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$251,670
|
|
Lupus
|
NIAID
|
5P01AI039824-12
|
0008
|
Candidate Genes for BXSB Lupus
|
MOHAN, CHANDRA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$246,046
|
|
Lupus
|
NIAID
|
5P01AI039824-12
|
0009
|
Mechanisms of the suppression of autoimmunity
|
SATTERTHWAITE, ANNE
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$246,047
|
|
Lupus
|
NCI
|
5S06GM008239-23
|
0014
|
Genetics of Lupus in Puerto Rico
|
QUINTERO-DEL RIO, ANA
|
PONCE SCHOOL OF MEDICINE
|
PR
|
$94,129
|
|
Lupus
|
NIAID
|
5S06GM008239-23
|
0014
|
Genetics of Lupus in Puerto Rico
|
QUINTERO-DEL RIO, ANA
|
PONCE SCHOOL OF MEDICINE
|
PR
|
$45,266
|
|
Lupus
|
NIGMS
|
5S06GM008239-23
|
0014
|
Genetics of Lupus in Puerto Rico
|
QUINTERO-DEL RIO, ANA
|
PONCE SCHOOL OF MEDICINE
|
PR
|
$473,244
|
|
Lupus
|
NIAID
|
5R01AI061061-05
|
|
Molecular Characterization of T-bet's Role in Immunity
|
WEINMANN, AMY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$282,026
|
|
